Cancer Genetics

Papers
(The H4-Index of Cancer Genetics is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
84. Continued utility of chromosome analysis for plasma cell disorders503
93. Enhancing cytogenetic abnormality detection through flow cytometry-guided B-Cell stimulated cultures137
34. Best practices for testing low-level mosaic variants:Recommendations from CGC somatic overgrowth and vascular anomalies working group85
24. Prediction of gene expression in NSCLC tumors and their microenvironment using an explainable machine learning model62
77. Cytogenomic characterization of ALK-negative ALCL cell lines DL-40 and Fe-PD50
135. Tumor deconvolution using comprehensive single-cell RNA sequencing cell type signatures49
27. Five-year experience of evaluating individuals at-risk for underlying genetic predisposition to hematologic malignancy45
96. A unique case presentation of pediatric spinal ependymoma with chromothripsis of chromosome 6: case report39
116. Integrating methylation profiling into adult brain tumor diagnostics - the Australian experience33
58. Improving the molecular diagnosis of SBDS-related disorders by identifying rare gene conversion events.33
64. A rare finding of triple KRAS mutations with OmniSeq® INSIGHT in a patient with colorectal adenocarcinoma30
40. Prioritization of defining and supportive diagnostic variants in pediatric tumors26
43. Challenges of classifying variants associated with disorders of somatic mosaicism and guideline creation26
2. Diagnostic next generation sequencing to detect MYD88 L265P in lymphoplasmacytic lymphoma compared to ddPCR25
Detection of VHL variant on multigene panel testing for hereditary breast cancer: Implications for genetic counselling24
Molecular determinants of clinical outcomes for anaplastic lymphoma kinase–positive non-small cell lung cancer in Chinese patients: A retrospective study23
Plasma cell-free DNA biomarkers as novel diagnostic and prognostic tools in breast cancer22
Next generation sequencing reveals spatio-temporal clonal heterogeneity in an aggressive relapsed/refractory multiple myeloma case18
LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185–5p/PLOD1/Akt/mTOR pathway18
1.2395298480988